Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Things seem to be in the works. Weak hands are being shaken out so cmmsgm can get shares. Read headline of health sciences PR; "for the marketing of biotech products". I'm holding and accumulating through Nov. 2010.
"The MPDD is approved by the FDA. What is necessary is to marry this device with the proprietary intervention therapy developed by Dr. Marcus which itself has its genesis in the treatment therapy pioneered by Hans Kraus, MD, the physician who
treated President John Kennedy for his Addisons Disease. Together, this intervention potentially can help millions of people around the world suffering from chronic back and neck pain and avoid unnecessary surgeries that are often unsuccessful in eliminating pain. I am one of those who had been diagnosed with compressed/bulging discs in C-2-C-7 and have tried many types of therapies including acupuncture, nerve blocks, facet injections and, recently was a candidate for a spinal fusion. Dr. Marcus’ MPDD and therapy changed all of that and I have been pain free for months. I also know that Dr. Marcus has had great results working with veterans of Iraq and Afghanistan who sustained significant painful back and neck injuries as a result of combat operations in those theaters of operation so the potential for benefit is clearly there. But as we all know, medicine in this country requires new innovative therapies pass muster with some of the most rigorous clinical trials in the world, so these things often take time. If shareholders are really interested in learning more about the MPDD and accompanying therapy, they should come to Dallas November 18-19 to the World Congress on Disabilities (www.thewcd.org) and attend the lecture given by Dr. Marcus on this subject. Indeed, attending the WCD will give you and any other shareholder who attends a first class perspective on the scope of what we do both in the civilian and military sectors. And yes, having FDA approval is generally regarded as a very important step in the process of gaining acceptance in the international and domestic medical community."
-Joe Valenzano, CEO EPGL
Obviously EPGL has or will have a major stake in the MPDD or why would they be doing all this promotion of it? They just announced the Health Sciences Division is for the marketing of Biotech products. Read the Headline again. I guarantee they will drop a PR on us in the future weeks outlining EPGL's acquisition or equity stake in the MPDD. Don't be caught without your shares when that happens. GUARANTEE. This thing is a screaming bargain right now.
what do you mean?
There we go. Some hitting 3s. EOD ask .0004 imho
matter of time.
What's happening on L2?
unfortunately im tapped in my account. I want more in a bad way.
Someone is going to come along and buy the remaining block of 3s and everyone who is waiting for 2s is going to say "Hey, I wanted in on the 3's. Too late. Watch.
Everyone should read the Q&A with CEO Joe Valenzano I posted earlier closely. There are some gems in there. He confirmed no reverse splits, MPDD is FDA approved and more. EPGL is a goldmine in my opinion with all that is already announced.
There's not another .0003 stock taking an FDA device to market with major Health Care ties, including US Military, that I know of.
Ask will be .0004 by EOD. Price (may) be .0004 EOD too. Just a feeling. Consolidation happening and hold-outs trying to tap 2s.
Exactly, I mean it's so obvious what's happening here. This is a .10 stock or more in the making here, imho.
EPGL is promoting the hell out of Dr. Marcus and the MPDD device. He published 3 articles over the summer in EP's magazine and digital website. There's two aspects here, the device itself and the proprietary therapy that goes with it. EPGL is marketing both to all it's resources including the WCD, where thousands of health care professionals gather and US Military people too. Dr. Marcus is a key speaker with Admiral Michael Mullens, Chairman Joint Chiefs of Staff scheduled to be Keynote. Read between the lines.
Absolutely agree with that. The company has not confirmed or denied anything regarding the MPDD device. They have only said more announcements are coming. Read the Q&A and ask yourself, why would a company open a Health Sciences Division for the purpose of "marketing" Biotech products and be so involved with the MPDD? It's plainly obvious.
EPGL has very close ties with US Military. Who needs the MPDD device right now more than the US Military for pain relief? Read between the lines, in my opinion.
I confirmed EPGL is taking MPDD device to the world starting here with our institutions. Read between the lines. Look at EPs close ties to the US Military. Dr. Marcus invented it, EP is taking it out to the health care world. Of course they have a stake in it and they are keeping it propietary at the moment is what I've confirmed.
EPGL CEO Q&A with Permission to Post 9-22-10
"While I usually do not respond to questions such as these from investors, I will make an exception in this instance largely because I am hopeful that by providing some clarification in this manner it might assuage any concerns of those who follow our company and are interested in it." - Joe Valenzano CEO, EPGL 9-22-10
Q Congratulations on the new EP Health Sciences Division opening. Is the MPDD device FDA approved and do you consider that an asset in getting it accepted not only domestically, but internationally as well?
AThe MPDD is approved by the FDA. What is necessary is to marry this device with the proprietary intervention therapy developed by Dr. Marcus which itself has its genesis in the treatment therapy pioneered by Hans Kraus, MD, the physician who
treated President John Kennedy for his Addisons Disease. Together, this intervention potentially can help millions of people around the world suffering from chronic back and neck pain and avoid unnecessary surgeries that are often unsuccessful in eliminating pain. I am one of those who had been diagnosed with compressed/bulging discs in C-2-C-7 and have tried many types of therapies including acupuncture, nerve blocks, facet injections and, recently was a candidate for a spinal fusion. Dr. Marcus’ MPDD and therapy changed all of that and I have been pain free for months. I also know that Dr. Marcus has had great results working with veterans of Iraq and Afghanistan who sustained significant painful back and neck injuries as a result of combat operations in those theaters of operation so the potential for benefit is clearly there. But as we all know, medicine in this country requires new innovative therapies pass muster with some of the most rigorous clinical trials in the world, so these things often take time. If shareholders are really interested in learning more about the MPDD and accompanying therapy, they should come to Dallas November 18-19 to the World Congress on Disabilities (www.thewcd.org) and attend the lecture given by Dr. Marcus on this subject. Indeed, attending the WCD will give you and any other shareholder who attends a first class perspective on the scope of what we do both in the civilian and military sectors. And yes, having FDA approval is generally regarded as a very important step in the process of gaining acceptance in the international and domestic medical community. But here again it is not so much the device itself as its application with the intervention therapy pioneered by Dr. Marcus that is important too.
Q You recently announced you have reached a restructure agreement with the major debt holders. With this restructure in place, can all your goals be accomplished without raising authorized share amounts or reverse split?
A We have reached an agreement in principle with our major debt holder, NIR and the details of that agreement need to be solidified and then voted on by shareholders. Nothing is going to be implemented without the expressed approval of our shareholder group. That being said, it is not our intention to implement a plan that will result in dilution for our shareholders. We are acutely cognizant of the negative vote of our shareholder group when a reverse split was proposed last year. Nothing in any of the press releases issued by our company makes mention of a reverse split or increase in authorized shares.
Q As we understand it, you are a major debt holder. Have you agreed to have more than 1/2 of your debt converted to shares too? Would this not mean you have more incentive than ever to raise shareholder equity?
A Yes, it is my intention to convert 50% of the amounts due and owing to me into equity as a condition of the restructuring agreement. Inasmuch as I am the second largest creditor next to NIR, I should think this would be viewed as a fairly important step and a reaffirmation of my commitment to this company and its mission. It also reinforces in me and I hope others in management additional incentive to try to increase shareholder value. Thus our value is aligned with those of our shareholders, a fact that tends to escape some people at times.
tap the 3s while you can. they weathered that storm well.
Ok, lets wait. Promise you will not render anymore speculation until then? I will if you will. Friends? :)
The CEO is one of the major debt holders and is converting his debt to EPGL shares also in the restructure. That's all I need to hear. He obviously has incentive to drive the shareprice throught the roof with new developments. It makes him richer too.
Shares are restricted and there will be a moritorium on conversion is my guess. This will allow shareprice to increase dramatically in the meantime and when conversion finally does happen, the ratio will be minute compared to now. Think about it. If shareprice is 10x what it is now or 100x the debt conversion ratio is reducing by that amount in linear fashion, massively reduced.
I spoke to Joe too last year. He never lied to me once. Although I agree with you that NIR are scumbags, the company has done good work, which I have seen you post youself.
I don't wish to keep arguing with you here, because I think we both agree the company does good work. Let's just let things play out and stop speculating on the past ok?
So says you. and furthermore, more than 1/2 the debt is off the books with the restructure. That is what I was saying. You didn't even know it was in the PR. Who is misleading who?
I contacted Joe Valenzano himself the CEO after listening to all this BS on RS. Here is what he said: "Why should we talk about something (reverse) that we are not doing? Anyone, including this crackpot can call me directly and I'll tell them that." End of story.
So feel free to call the CEO himself and ask him.
I never said the other 1/2 is wiped out. I said with higher share price the conversion ratio makes a reverse unecessary at all. This is what the company is doing, which is exactly what it ALSO said in the PR; "Our main goal now is to build shareholder equity to a level befitting the positive developments to be announced shortly.”
Stick with the facts as they are, not as you speculate.
I'm done with you. You are not engaging in genuine conversations. Everything is "BS" and "POS" to you. I just showed you where your numbers are off with the restructure.
Again, from the PR:
"Exceptional Parent (EP) magazine, has announced that, in a positive development, the Company has reached agreement in principle with its major debt holders to convert more than half of its outstanding debt to shareholder equity."
You said: "I can agree with one thing, however, the stock is headed much higher." We do agree on that.
The company PR said more major shareholders have agreed to convert more than 1/2 the debt:
"the parent company of Exceptional Parent (EP) magazine, has announced that, in a positive development, the Company has reached agreement in principle with its major debt holders to convert more than half of its outstanding debt to shareholder equity."
so there you go.
Once again, your numbers are off and you appear to be intentionally misleading people. With the restructure in place these numbers will be dramatically different for the better. Plus with higher shareprice the conversion makes a reverse unecessary.
Stop misleading people here.
Listen, if we lived in a vacuum you could be right. But we don't. If restructure is passed, which it will be, 1/2 the debt is gone off the books. Then new contracts and revenues come in, the books start looking a lot better and shareholder equity rises with the stock. NIR conversion by the time the restructure is enacted will not require a reverse.
This is my speculation here. Either way, this stock is headed much higher from here.
All you are doing Iblong, is telling us all what we already know, the past. Stick to the present know facts for the future, please otherwise you lose credibility yourself. With all respect.
EPGL is going to correct its undervalued nature and when it does, it will be hard and fast. We're just seeing the beginning of the correction here with 300% up in last week. The restructure agreement along with shareprice increase will make the remaining debt conversion a fraction of what it has been.
How many .0003 companies have an FDA cleared device they are introducing to the health care market shortly? Undervalued, when there are certain micros out there reight now at .01 without FDA clearance? You be the judge.
I go by the present news, not the past. They announced a new restructure agreement and RS is not part of it. In fact they explicitly said they intend to drive up equity. They have announced the Health Sciences division is open and share price is up 300% in a week.
Those are the facts right now, not the past.
Nice! Thanks for the post.
You know there's more news coming.
This is running past last year's high of .0024. No doubt. It's just a matter of when. By November WCD conference I predict. MPDD presentation November 17-18 according to last PR
"This intervention therapy addresses a market which has been estimated to be $85 billion in size and Dr. Marcus’ approach can help potentially millions of people experience relief from chronic pain for the first time," said Joe Valenzano, the CEO of EPGL. This marks a significant expanded direction for EPGL."
Totally agree with that. Watched it happen with DNDN and NEPH
Agreed. "Our main goal now is to build shareholder equity to a level befitting the positive developments to be announced shortly.” Says it all.
November 17-18th. Mark on your calendar. MPDD device presentation at WCD in Dallas.
Also, noticed that www.ephealthsciences.com is under construction. URL is owned by EPGL